New peptide to improve healing of diabetic wounds
Official title: Novel peptide for enhancing diabetic wound healing
Funded at Scarless Laboratories, INC. · NIH-10814133 · Data updated 2026-11-12
This study is testing a new treatment to help heal stubborn wounds in people with diabetes, aiming to speed up healing and reduce complications by improving how the body repairs itself.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scarless Laboratories, INC. NIH-funded |
| Lab location | 1 site (Beverly Hills, United States) |
| Project start | September 24, 2021 |
| Project end | March 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $942,603 |
| NIH project number | 5R44DK131648-03 |
| Project ID | NIH-10814133 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with diabetes who are experiencing chronic non-healing wounds.
✕Less likely to help
Patients without diabetes or those with acute wounds may not benefit from this research.
What this research studies
This research focuses on developing a novel peptide that aims to enhance the healing process of chronic wounds in diabetic patients. It addresses the challenges faced by individuals with diabetes, who often suffer from non-healing ulcers due to impaired cellular functions and poor blood flow. The approach involves restoring the molecular and cellular processes necessary for effective wound repair, potentially leading to faster healing and reduced risk of complications. Patients participating in this research may receive treatments that directly target the underlying issues affecting their wound healing.
Why it matters
Potential benefit: If successful, this research could significantly improve the healing rates of diabetic wounds, reducing the risk of infections and amputations.
How similar studies have gone: Previous research has shown promise in using novel peptides for wound healing, indicating that this approach could be effective.
Where this research is happening
-
Scarless Laboratories, INC.
Beverly Hills, United States Active
Researchers
- Principal investigator: Zheng, Zhong — Scarless Laboratories, INC.
- Study coordinator: Zheng, Zhong
Related research
Other NIH-funded projects on the same topics.
-
Immunomodulatory therapy to speed up healing after oral cavity injuries in kids
A new approach using a drug called FTY720 aims to improve healing and reduce pain after oral injuries or palate surgery in children.
-
Aiming to slow dangerous lung inflammation to help fight bacterial infections like tuberculosis
A patient-facing program tests whether stopping a specific inflammatory cell (Spp1+ macrophages) from overreacting can help control tuberculosis and possibly improve outcomes in other inflammatory diseases.
-
Engineered protein materials to study wound healing and blood vessels
A researcher team at the University of New England is studying how the environment around a protein changes its behavior to better understand wound healing and blood vessel formation.
-
Understanding how healing tissue uses tiny messengers and scaffolds to repair wounds
A study to learn how cells talk to each other and how tiny vesicles and the extracellular matrix help skin wounds heal better.
-
Hormone signals and sex differences in how wounds heal
This grant explores how male- and female-specific hormones affect wound healing and scarring, with the goal of improving treatments for people who heal poorly.
-
Therapeutic extracellular vesicles to boost skin wound healing
A research grant is exploring how tiny cell messengers called extracellular vesicles can be engineered to improve skin wound repair in injury models.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.